Skip to main content

Eo-soo Kim

Yonsei University · 医学

研究室紹介

Professor Eo-soo Kim's research lab focuses on the intersection of neuropsychiatry, metabolic health, and neurocognitive function, with a strong emphasis on understanding and mitigating cognitive and metabolic side effects associated with psychiatric treatments. The lab investigates the neural mechanisms underlying cognitive decline in conditions such as atrial fibrillation and Wernicke’s encephalopathy, while also exploring pharmacological interventions—like metformin and alpha-lipoic acid—to improve cognitive outcomes and metabolic parameters in psychiatric and neurodegenerative disorders. A key research direction involves evaluating the translational potential of metabolic modulators in neuroprotection and cognitive preservation.

cognitive dysfunctionmetabolic side effectsneuropsychiatryneurocognitive mechanismspsychopharmacology

Research Overview

Papers
122
Total Citations
3,274
Papers (5y)
35
Primary Field
医学

Research Output Trend

Figures are computed from collected data and may differ slightly.

Publications per year (5y)
35total
2022
2023
2024
2025
2026
Citations per year (5y)
403total
20222023202420252026

Selected Papers

15
1
Article|95 citations·2019
Atrial Fibrillation Catheter Ablation Improves 1-Year Follow-Up Cognitive Function, Especially in Patients With Impaired Cognitive Function
Moo‐Nyun Jin, Tae‐Hoon Kim, Ki‐Woon Kang, Hee Tae Yu, Jae‐Sun Uhm, Boyoung Joung, Moon‐Hyoung Lee, Eosu Kim, Hui‐Nam Pak
SJR Q1Circulation Arrhythmia and ElectrophysiologyOA

BACKGROUND: Although atrial fibrillation (AF) has a risk of cognitive dysfunction, it is not clear whether AF catheter ablation improves or worsens cognitive function. This prospective case-control study sought to assess the 1-year serial changes in the cognitive function with or without AF catheter ablation. METHODS: We evaluated the Montreal Cognitive Assessment score in 308 patients (71.4% male, 60.6±9.1 years of age, 34.1% persistent AF) who underwent AF ablation (ablation group) and 50 AF p

Cardiology and Cardiovascular MedicineMedicine
2
Article|75 citations·2009
Reduced activation in the mirror neuron system during a virtual social cognition task in euthymic bipolar disorder
Eosu Kim, Young‐Chul Jung, Jeonghun Ku, Jae‐Jin Kim, Hyeongrae Lee, So Young Kim, Sun I. Kim, Hyun Sang Cho
SJR Q1Progress in Neuro-Psychopharmacology and Biological PsychiatryOA
Social PsychologyPsychology
3
Article|58 citations·2008
A Preliminary Investigation of α-Lipoic Acid Treatment of Antipsychotic Drug-Induced Weight Gain in Patients With Schizophrenia
Eosu Kim, Dong-Wha Park, Song-Hee Choi, Jae‐Jin Kim, Hyun Sang Cho
SJR Q2Journal of Clinical PsychopharmacologyOA

Weight gain and other metabolic disturbances have now become discouraging, major side effects of atypical antipsychotic drugs (AAPDs). The novel strategies required to counteract these serious consequences, however, should avoid modulating the activities of the neurotransmitter receptors involved because those receptors are the therapeutic targets of AAPDs. Adenosine monophosphate-activated protein kinase is an enzyme that plays a pivotal role in energy homeostasis. We hypothesized that alpha-li

BiochemistryBiochemistry, Genetics and Molecular Biology
4
Article|48 citations·2008
Mammillothalamic functional connectivity and memory function in Wernicke's encephalopathy
Eosu Kim, Jeonghun Ku, Kee Namkoong, Wonho Lee, Kang Soo Lee, Jiyeon Park, Su Young Lee, Jae‐Jin Kim, Sun I. Kim, Young‐Chul Jung
SJR Q1BrainOA

There is still debate over the neural mechanisms underlying pathogenic and even recovery processes of Wernicke's encephalopathy. Therefore, we attempted to validate the usefulness of resting-state functional connectivity analysis in assessing memory function and its neural correlation with the mammillothalamic tract in patients recovering from Wernicke's encephalopathy. Seven chronic alcoholics recovering from Wernicke's encephalopathy, 14 alcoholic comparisons without Wernicke's encephalopathy,

NeurologyMedicine
5
Article|44 citations·2024
Reconsidering repurposing: long-term metformin treatment impairs cognition in Alzheimer’s model mice
So Yeon Cho, Eun Woo Kim, Soo Jin Park, Benjamin U. Phillips, Jihyeon Jeong, Hyunjeong Kim, Christopher J. Heath, Daehwan Kim, Yurim Jang, Laura López‐Cruz, Lisa M. Saksida, Timothy J. Bussey
SJR Q1Translational PsychiatryOA

Abstract Metformin, a primary anti-diabetic medication, has been anticipated to provide benefits for Alzheimer’s disease (AD), also known as “type 3 diabetes”. Nevertheless, some studies have demonstrated that metformin may trigger AD pathology and even elevate AD risk in humans. Despite this, limited research has elucidated the behavioral outcomes of metformin treatment, which would hold significant translational value. Thus, we aimed to perform thorough behavioral research on the prolonged adm

Molecular BiologyBiochemistry, Genetics and Molecular Biology
6
Article|34 citations·2015
Utility of the Montreal Cognitive Assessment (MoCA) and its subset in HIV-associated neurocognitive disorder (HAND) screening
Woo Jung Kim, Nam Su Ku, Youngjoon Lee, Jin Young Ahn, Sun Bean Kim, H.W. Ahn, Kyung‐Wook Hong, Joon Young Song, Hee Jin Cheong, Woo Joo Kim, June Myung Kim, Kee Namkoong
SJR Q1Journal of Psychosomatic ResearchOA
VirologyImmunology and Microbiology
7
Article|32 citations·2020
Plasma Clusterin as a Potential Link Between Diabetes and Alzheimer Disease
Jung-Hee Ha, Min Kyong Moon, Hyunjeong Kim, Minsun Park, So Yeon Cho, Jimin Lee, Jun‐Young Lee, Eosu Kim
SJR Q1The Journal of Clinical Endocrinology & MetabolismOA

OBJECTIVE: Plasma clusterin, a promising biomarker of Alzheimer disease (AD), has been associated with diabetes mellitus (DM). However, clusterin has not been investigated considering a relationship with both DM and AD. In this study, we aimed to investigate the individual and interactive relationships of plasma clusterin levels with both diseases. DESIGN: Cross-sectional observation study. METHODS: We classified participants by the severity of cognitive (normal cognition, mild cognitive impairm

OncologyMedicine
8
Article|32 citations·2016
Adjunctive α-lipoic acid reduces weight gain compared with placebo at 12 weeks in schizophrenic patients treated with atypical antipsychotics
Nam Wook Kim, Yul-Mai Song, Eosu Kim, Hyun Sang Cho, Keun‐Ah Cheon, Sujin Kim, Jin Young Park
SJR Q2International Clinical PsychopharmacologyOA

α-Lipoic acid (ALA) has been reported to be effective in reducing body weight in rodents and obese patients. Our previous open trial showed that ALA may play a role in reducing weight gain in patients with schizophrenia on atypical antipsychotics. The present study evaluated the efficacy of ALA in reducing weight and BMI in patients with schizophrenia who had experienced significant weight gain since taking atypical antipsychotics. In a 12-week, double-blind randomized placebo-controlled study,

BiochemistryBiochemistry, Genetics and Molecular Biology
9
Article|32 citations·2010
Deficits in Eye Gaze During Negative Social Interactions in Patients With Schizophrenia
Soo‐Hee Choi, Jeonghun Ku, Kiwan Han, Eosu Kim, Sun I. Kim, Jun-Young Park, Jae‐Jin Kim
SJR Q3The Journal of Nervous and Mental DiseaseOA

Impaired social functioning has been reported in patients with schizophrenia. This study aimed to examine characteristics of interpersonal behaviors in patients with schizophrenia during various social interactions using the virtual reality system. Twenty-six patients and 26 controls engaged in the virtual conversation tasks, including 3 positive and 3 negative emotion-laden conversations. Eye gaze and other behavioral parameters were recorded during the listening and answering phases. The amoun

Experimental and Cognitive PsychologyPsychology
10
Article|30 citations·2014
Metabolomic Signatures in Peripheral Blood Associated with Alzheimer's Disease Amyloid-β-Induced Neuroinflammation
Eosu Kim, Young‐Sang Jung, Hyunjeong Kim, Jin-Sup Kim, Minsun Park, Jihyeon Jeong, Su Kyoung Lee, Ho‐Geun Yoon, Geum‐Sook Hwang, Kee Namkoong
SJR Q1Journal of Alzheimer s DiseaseOA

Discovery of biomarkers in peripheral blood is a crucial step toward the early diagnosis and repetitive monitoring of treatment response for Alzheimer's disease (AD). Metabolomics is a promising technology that can identify unbiased biomarkers. To explore potential blood biomarkers for AD via metabolic profiling with high-resolution magic angle spinning nuclear magnetic resonance techniques, we identified changes in peripheral blood metabolomic profiles in response to amyloid-β (Aβ)-induced neur

Molecular BiologyBiochemistry, Genetics and Molecular Biology
11
Article|30 citations·2016
Cholinesterase Inhibitor Donepezil Increases Mitochondrial Biogenesis through AMP-Activated Protein Kinase in the Hippocampus
Eosu Kim, Minsun Park, Jihyeon Jeong, Hyunjeong Kim, Su Kyoung Lee, Eun Lee, Byoung Hoon Oh, Kee Namkoong
SJR Q1NeuropsychobiologyOA

OBJECTIVE: Donepezil, a widely prescribed drug for Alzheimer's disease (AD), is now considered to have multimodal actions beyond cholinesterase inhibition. We aimed to see whether donepezil enhances mitochondrial biogenesis and relevant signaling pathways since mitochondrial dysfunction is a key feature of the hypometabolic AD brain. METHODS: As a metabolic gauge, AMP-activated protein kinase (AMPK) was investigated as a tentative mediator of neurometabolic action of donepezil. Changes in phosph

Molecular BiologyBiochemistry, Genetics and Molecular Biology
12
Article|30 citations·2022
Relationship Between Adipokines, Cognition, and Brain Structures in Old Age Depending on Obesity
Jung-Hee Ha, Seyul Kwak, Keun You Kim, Hyunjeong Kim, So Yeon Cho, Minae Kim, Juneyoung Lee, Eosu Kim
SJR Q1The Journals of Gerontology Series A

BACKGROUND: Adipokines such as leptin and adiponectin are associated with cognitive function. Although adiposity crucially affects adipokine levels, it remains unclear whether the relationship between adipokines and cognition is influenced by obesity. METHODS: We enrolled 171 participants and divided them into participants with obesity and without obesity to explore the effect of obesity on the relationship between adipokines and cognition. In addition to plasma levels of leptin and adiponectin,

Endocrine and Autonomic SystemsNeuroscience
13
Article|29 citations·2011
AMPK γ2 subunit gene PRKAG2 polymorphism associated with cognitive impairment as well as diabetes in old age
Eosu Kim, Sung Hee Lee, Kang Soo Lee, Hae‐Kwan Cheong, Kee Namkoong, Chang Hyung Hong, Byoung Hoon Oh
SJR Q1Psychoneuroendocrinology
Molecular BiologyBiochemistry, Genetics and Molecular Biology
14
Article|28 citations·2023
Restless leg syndrome and risk of all-cause dementia: a nationwide retrospective cohort study
Keun You Kim, Eun Hwa Kim, Myeongjee Lee, Jung-Hee Ha, Inkyung Jung, Eosu Kim
SJR Q1Alzheimer s Research & TherapyOA

BACKGROUND: Restless leg syndrome (RLS) is associated with poor sleep quality, depression or anxiety, poor dietary patterns, microvasculopathy, and hypoxia, all of which are known risk factors for dementia. However, the relationship between RLS and incident dementia remains unclear. This retrospective cohort study aimed to explore the possibility that RLS could be deemed as a non-cognitive prodromal feature of dementia. METHODS: This was a retrospective cohort study using the Korean National Hea

EpidemiologyMedicine
15
Article|26 citations·2009
Nonverbal Social Behaviors of Patients With Bipolar Mania During Interactions With Virtual Humans
Eosu Kim, Jeonghun Ku, Jae‐Jin Kim, Hyeongrae Lee, Kiwan Han, Sun I. Kim, Hyun Sang Cho
SJR Q3The Journal of Nervous and Mental DiseaseOA

It has been proposed that positive emotional biases could make bipolar manic (BM) patients maintain abnormally approaching behaviors during social interactions. To test this hypothesis, we measured interpersonal distance (IPD) and gaze angle of BM patients and normal controls (NCs) during social interaction in immersive virtual environment. Overall, IPDs of BM patients (n = 20) were greater than those of normal controls (n = 20). The IPD difference was even greater between NCs and BM patients wi

Experimental and Cognitive PsychologyPsychology

Research Areas

Psychiatry and Mental healthNeurologyMolecular BiologyCognitive NeurosciencePhysiologySocial Psychology

Eo-soo Kimの研究をNubintでさらに深く

この研究室の論文をアプリで開き、AIと共に読み、要約し、引用しましょう。